Effect of Antihypertensive Agents - Captopril and Nifedipine - on the Functional Properties of Rat Heart Mitochondria

Overview

Journal Iran J Basic Med Sci

Publisher Mashhad University of Medical Sciences

Specialty General Medicine

Date 2016 Aug 3

PMID 27482342

Citations 4

Authors

Ivana Kancirova

Magdalena Jasova

Iveta Waczulikova

Tana Ravingerova

Attila Ziegelhoffer

Miroslav Ferko

Affiliations

Soon will be listed here.

Abstract

Objectives: Investigation of acute effect on cellular bioenergetics provides the opportunity to characterize the possible adverse effects of drugs more comprehensively. This study aimed to investigate the changes in biochemical and biophysical properties of heart mitochondria induced by captopril and nifedipine antihypertensive treatment.

Materials And Methods: Male, 12-week-old Wistar rats in two experimental models (in vivo and in vitro) were used. In four groups, the effects of escalating doses of captopril, nifedipine and combination of captopril + nifedipine added to the incubation medium (in vitro) or administered per os to rat (in vivo) on mitochondrial ATP synthase activity and membrane fluidity were monitored.

Results: In the in vitro model we observed a significant inhibitory effect of treatment on the ATP synthase activity (P<0.05) with nonsignificant differences in membrane fluidity. Decrease in the value of maximum reaction rate Vmax (P<0.05) without any change in the value of Michaelis-Menten constant Km, indicative of a noncompetitive inhibition, was presented. At the in vivo level, we did not demonstrate any significant changes in the ATP synthase activity and the membrane fluidity in rats receiving captopril, nifedipine, and combined therapy.

Conclusion: In vitro kinetics study revealed that antihypertensive drugs (captopril and nifedipine) directly interact with mitochondrial ATP synthase. In vivo experiment did not prove any acute effect on myocardial bioenergetics and suggest that drugs do not enter cardiomyocyte and have no direct effect on mitochondria.

Citing Articles

Drug-induced mitochondrial toxicity: Risks of developing glucose handling impairments.

Kuretu A, Arineitwe C, Mothibe M, Ngubane P, Khathi A, Sibiya N Front Endocrinol (Lausanne). 2023; 14:1123928.

PMID: 36860368 PMC: 9969099. DOI: 10.3389/fendo.2023.1123928.

Mitochondrial Effects of Common Cardiovascular Medications: The Good, the Bad and the Mixed.

Betiu A, Noveanu L, Hancu I, Lascu A, Petrescu L, Maack C Int J Mol Sci. 2022; 23(21).

PMID: 36362438 PMC: 9656474. DOI: 10.3390/ijms232113653.

Dichloroacetate as a metabolic modulator of heart mitochondrial proteome under conditions of reduced oxygen utilization.

Andelova N, Waczulikova I, Kunstek L, Talian I, Ravingerova T, Jasova M Sci Rep. 2022; 12(1):16348.

PMID: 36175475 PMC: 9522880. DOI: 10.1038/s41598-022-20696-5.

Are antibacterial effects of non-antibiotic drugs random or purposeful because of a common evolutionary origin of bacterial and mammalian targets?.

Dalhoff A Infection. 2020; 49(4):569-589.

PMID: 33325009 PMC: 7737717. DOI: 10.1007/s15010-020-01547-9.

References

TAUSSKY H, SHORR E . A microcolorimetric method for the determination of inorganic phosphorus. J Biol Chem. 1953; 202(2):675-85. View

Taddei S . Combination therapy in hypertension: what are the best options according to clinical pharmacology principles and controlled clinical trial evidence?. Am J Cardiovasc Drugs. 2015; 15(3):185-94. DOI: 10.1007/s40256-015-0116-5. View

Chen J, Rao B, Chang J, Liao X, Cao Y . [Effects of captopril on myocardial energy metabolism in mice with viral myocarditis]. Zhongguo Wei Zhong Bing Ji Jiu Yi Xue. 2003; 15(8):485-8. View

White P . Calcium channel blockers. AACN Clin Issues Crit Care Nurs. 1992; 3(2):437-46. DOI: 10.4037/15597768-1992-2015. View

Law M, Wald N, Morris J . Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy. Health Technol Assess. 2003; 7(31):1-94. DOI: 10.3310/hta7310. View

Das A, Harris D . Mitochondrial ATP synthase regulation in heart: defects in hypertension are restored after treatment with captopril. Cardioscience. 1992; 3(4):227-32. View

Almotrefi A, Dzimiri N . Effects of beta-adrenoceptor blockers on mitochondrial ATPase activity in guinea pig heart preparations. Eur J Pharmacol. 1992; 215(2-3):231-6. DOI: 10.1016/0014-2999(92)90032-y. View

Vrbjar N, Dzurba A, Ziegelhoffer A . Enzyme kinetics and the activation energy of (Na,K)-ATPase in ischaemic hearts: influence of the duration of ischaemia. Gen Physiol Biophys. 1994; 13(5):405-11. View

Kubo T, Fujie K, Yamashita M, Misu Y . Antihypertensive effects of nifedipine on conscious normotensive and hypertensive rats. J Pharmacobiodyn. 1981; 4(4):294-300. DOI: 10.1248/bpb1978.4.294. View

10.

Kunes J, Kadlecova M, Vaneckova I, Zicha J . Critical developmental periods in the pathogenesis of hypertension. Physiol Res. 2012; 61(Suppl 1):S9-17. DOI: 10.33549/physiolres.932364. View

11.

Schneider J, Younes A . Binding of bepridil to isolated rat heart mitochondria. Basic Res Cardiol. 1989; 84(6):623-30. DOI: 10.1007/BF01906947. View

12.

Horvat A, Momic T, Petrovic S, Nikezic G, Demajo M . Selective inhibition of brain Na,K-ATPase by drugs. Physiol Res. 2005; 55(3):325-338. DOI: 10.33549/physiolres.930696. View

13.

Meyers R, Siu A . Pharmacotherapy review of chronic pediatric hypertension. Clin Ther. 2011; 33(10):1331-56. DOI: 10.1016/j.clinthera.2011.09.003. View

14.

Postnov Y, Orlov S, Budnikov Y, Doroschuk A, Postnov A . Mitochondrial energy conversion disturbance with decrease in ATP production as a source of systemic arterial hypertension. Pathophysiology. 2007; 14(3-4):195-204. DOI: 10.1016/j.pathophys.2007.09.002. View

15.

Ziegelhoffer A, Mujkosova J, Ferko M, Vrbjar N, Ravingerova T, Ulicna O . Dual influence of spontaneous hypertension on membrane properties and ATP production in heart and kidney mitochondria in rat: effect of captopril and nifedipine, adaptation and dysadaptation. Can J Physiol Pharmacol. 2012; 90(9):1311-23. DOI: 10.1139/y2012-107. View

16.

Shi C, Wu F, Xu J . Incorporation of β-sitosterol into mitochondrial membrane enhances mitochondrial function by promoting inner mitochondrial membrane fluidity. J Bioenerg Biomembr. 2012; 45(3):301-5. DOI: 10.1007/s10863-012-9495-3. View

17.

Millgard J, Hagg A, Sarabi M, Lind L . Captopril, but not nifedipine, improves endothelium-dependent vasodilation in hypertensive patients. J Hum Hypertens. 1998; 12(8):511-6. DOI: 10.1038/sj.jhh.1000665. View

18.

Paulis L, Steckelings U, Unger T . Key advances in antihypertensive treatment. Nat Rev Cardiol. 2012; 9(5):276-85. DOI: 10.1038/nrcardio.2012.33. View

19.

Eckmann J, Eckert S, Leuner K, Muller W, Eckert G . Mitochondria: mitochondrial membranes in brain ageing and neurodegeneration. Int J Biochem Cell Biol. 2012; 45(1):76-80. DOI: 10.1016/j.biocel.2012.06.009. View

20.

Pinterova M, Kunes J, Zicha J . Altered neural and vascular mechanisms in hypertension. Physiol Res. 2011; 60(3):381-402. DOI: 10.33549/physiolres.932189. View